Enclitide Chloride (MK-0616)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Enclitide Chloride (MK-0616), covering 2023-12-06 to 2023-12-06. Get the full timeline:
Most recent: Clinical Trial Update: A Study of the Efficacy and Safety of Enclitide Chloride (MK-0616 Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-008) [Phase 2]